Title:Use of Anti-VEGF Drugs in Retinal Vein Occlusions
Volume: 21
Issue: 12
Author(s): Manuel AP Vilela*
Affiliation:
- Medical School, Federal University of Health Sciences of Porto Alegre, Brazil and Ophthalmological Service, Cardiology Institute, University Foundation of Cardiology, Porto Alegre,Brazil
Keywords:
Retinal vein occlusion, branch retinal vein occlusion, central retinal vein occlusion, anti-VEGF, ranibizumab,
aflibercept, bevacizumab.
Abstract: Retinal vein occlusion (RVO) is one of the most prevalent causes of visual loss in the
Western World. Its pathogenesis is still not completely known. Chronic macular edema and ischemia
compromise the functional and anatomical status of the retina. Antivascular endothelial growth factor
(anti-VEGF) injections have demonstrated better results than other previous options, including observation
or laser therapy. This narrative review aims to analyze the current aspects related to these
drugs.